Lipopolysaccharide: Basic Biochemistry, Intracellular Signaling, and Physiological Impacts in the Gut

被引:115
作者
Rhee, Sang Iioon [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Div Diegestive Diseases, 675 Charles E Young Dr South, Los Angeles, CA 90095 USA
关键词
Lipopolysaccharides; Toll-like receptors; Inflammatory bowel diseases;
D O I
10.5217/ir.2014.12.2.90
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Lipopolysaccharide (LPS), a main constituent of Gram-negative bacterial membrane, specifically activates Toll-like receptor 4, leading to the production of pleiotropic cytokines/chemokines which in turn regulate inflammatory and innate and subsequent adaptive immune responses. Given that human gut harbors a large collection of commensal bacteria, LPS released by gut microbes is able to make the great impact on gut homeostasis through the intracellular signaling pathways engaged by host-microbial interaction. Emerging evidence indicates that LPS in the gut has a potency to elicit the pathogenesis of intestinal inflammatory diseases such as inflammatory bowel disease and necrotizing enterocolitis. In this review, we discuss the current understanding of the basic biochemistry of LPS, LPS-induced intracellular signaling, and physiological impacts of LPS in the intestine.
引用
收藏
页码:90 / 95
页数:6
相关论文
共 42 条
[1]   TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells [J].
Abreu, MT ;
Arnold, ET ;
Thomas, LS ;
Gonsky, R ;
Zhou, YH ;
Hu, B ;
Arditi, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (23) :20431-20437
[2]   TLR accessory molecules [J].
Akashi-Takamura, Sachiko ;
Miyake, Kensuke .
CURRENT OPINION IN IMMUNOLOGY, 2008, 20 (04) :420-425
[3]   Targeting bacterial endotoxin - Two sides of a coin [J].
Bosshart, Herbert ;
Heinzelmann, Michael .
SIGNAL TRANSDUCTION PATHWAYS, PT D: INFLAMMATORY SIGNALING PATHWAYS AND NEUROPATHOLOGY, 2007, 1096 :1-17
[4]   Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease [J].
Cario, E ;
Podolsky, DK .
INFECTION AND IMMUNITY, 2000, 68 (12) :7010-7017
[5]   PTEN regulates TLR5-induced intestinal inflammation by controlling Mal/TIRAP recruitment [J].
Choi, Yoon Jeong ;
Jung, Jane ;
Chung, Hyo Kyun ;
Im, Eunok ;
Rhee, Sang Hoon .
FASEB JOURNAL, 2013, 27 (01) :243-254
[6]   TRIF Mediates Toll-like Receptor 5-induced Signaling in Intestinal Epithelial Cells [J].
Choi, Yoon Jeong ;
Im, Eunok ;
Chung, Hyo Kyun ;
Pothoulakis, Charalabos ;
Rhee, Sang Hoon .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (48) :37570-37578
[7]   GENETIC BASIS FOR UNRESPONSIVENESS TO LIPOPOLYSACCHARIDE IN C57BL-10CR MICE [J].
COUTINHO, A ;
MEO, T .
IMMUNOGENETICS, 1978, 7 (01) :17-24
[8]   Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children [J].
De Palma, Giada ;
Nadal, Inmaculada ;
Medina, Marcela ;
Donat, Ester ;
Ribes-Koninckx, Carmen ;
Calabuig, Miguel ;
Sanz, Yolanda .
BMC MICROBIOLOGY, 2010, 10
[9]   A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease [J].
Fort, MM ;
Mozaffarian, A ;
Stöver, AG ;
Correia, JD ;
Johnson, DA ;
Crane, RT ;
Ulevitch, RJ ;
Persing, DH ;
Bielefeldt-Ohmann, H ;
Probst, P ;
Jeffery, E ;
Fling, SP ;
Hershberg, RM .
JOURNAL OF IMMUNOLOGY, 2005, 174 (10) :6416-6423
[10]  
GLODE LM, 1977, J IMMUNOL, V119, P162